Curis
CRIS
#10233
Rank
S$19.36 M
Marketcap
S$1.50
Share price
-10.08%
Change (1 day)
-70.01%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -S$42.89 Million

According to Curis's latest financial reports the company's current earnings are S$11.65 Million. In 2024 the company made an earning of -S$55.24 Million, an increase over its 2023 earnings that were of -S$58.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$42.89 Million-22.36%
2024 -S$55.24 Million-5.77%
2023 -S$58.63 Million-13.1%
2022 -S$67.46 Million27.52%
2021 -S$52.9 Million65.09%
2020 -S$32.05 Million-9.1%
2019 -S$35.25 Million-4.73%
2018 -S$37 Million-41.95%
2017 -S$63.74 Million-14.37%
2016 -S$74.43 Million3.55%
2015 -S$71.88 Million271.52%
2014 -S$19.35 Million76.64%
2013 -S$10.96 Million
2011 -S$9.31 Million27.76%
2010 -S$7.29 Million-43.87%
2009 -S$12.98 Million-23.44%
2008 -S$16.95 Million56.66%
2007 -S$10.82 Million-16.71%
2006 -S$12.99 Million-36.92%
2005 -S$20.59 Million156.25%
2004 -S$8.04 Million-37.24%
2003 -S$12.81 Million-93.34%
2002 -S$0.2 Billion86.79%
2001 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exelixis
EXEL
S$1.12 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-S$79.92 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.34 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.30 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.37 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$31.93 Million-24.06%๐Ÿ‡บ๐Ÿ‡ธ USA